Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin- related compounds

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1587-1591

  Wakabayashi, Hiroyuki ^a   Abe, Shigeru ^b   Teraguchi, Susumu ^a   Hayasawa, Hirotoshi ^a   Yamaguchi, Hideyo ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; LACTOFERRIN; TRIAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CATTLE; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031807119     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1587     Document Type: Article

References (25)

1. Abe, S., T. Satoh, Y. Tokuda, S. Tansho, and H. Yamaguchi. 1994. A rapid colorimetric assay for determination of leukocyte-mediated inhibition of mycelial growth of Candida albicans. Microbiol. Immunol. 38:385-388.
2. Bellamy, W., M. Takase, K. Yamauchi, H. Wakabayashi, K. Kawase, and M. Tomita. 1992. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1121:130-136.
3. Bellamy, W., K. Yamauchi, H. Wakabayashi, M. Takase, N. Takakura, S. Shimamura, and M. Tomita. 1994. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett. Appl. Microbiol. 18:230-233.
4. Ben-Yaacov, R., S. Knoller, G. A. Caldwell, J. M. Becker, and Y. Koltin. 1994. Candida albicans gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene. Antimicrob. Agents Chemother. 38:648-652.
5. Britigan, B. E., M. B. Hayek, B. N. Doebbeling, and R. B. Fick, Jr. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61: 5049-5055.
6. Eliopoulos, G. M., and R. C. Moellering. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
7. Gutteberg, T. J., B. Haneberg, and T. Jorgensen. 1984. The latency of serum acute proteins in meningococcal septicaemia, with special emphasis on lactoferrin. Clin. Chim. Acta 136:173-178.
8. Hay, R. J. 1990. Overview of studies of fluconazole in oropharyngeal candidiasis. Rev. Infect. Dis. 12(Suppl. 3):334-337.
9. Kan, V. L., A. Geber, and J. E. Bennett. 1996. Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion. Antimicrob. Agents Chemother. 40:1717-1719.
10. Lenander-Lumikari, M., and I. Johansson. 1995. Effect of saliva composition on growth of Candida albicans and Torulopsis glabrata. Oral Microbiol. Immunol. 10:233-240.
11. Li, Y. M., A. X. Tan, and H. Vlassara. 1995. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nature Med. 1:1057-1061.
12. Martinez-Suarez, J. V., and J. L. Rodriguez-Tudela. 1996. In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates. Antimicrob. Agents Chemother. 40: 1277-1279.
13. Masson, P. L., J. F. Heremans, and C. H. Dive. 1966. An iron-binding protein common to many external secretions. Clin. Chim. Acta 14:735-739.
14. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Nikawa, H., L. P. Samaranayake, J. Tenovuo, K. M. Pang, and T. Hamada. 1993. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Arch. Oral Biol. 38:1057-1063.
16. Odds, F. C. 1988. Candida and candidosis: a review and bibliography, 2nd ed. Balliere Tindall, London, United Kingdom.
17. Odds, F. C., A. Cockayne, J. Hayward, and A. B. Abbott. 1985. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. J. Gen. Microbiol. 131:2581-2589.
18. Odds, F. C., J. Schmid, and D. R. Soll. 1990. Epidemiology of Candida infections in AIDS, p. 67-74. In H. Vanden Bossche et al. (ed.), Mycoses in AIDS patients. Plenum Press, New York, N.Y.
19. Okutomi, T., S. Abe, S. Tansho, H. Wakabayashi, K. Kawase, and H. Yamaguchi. 1997. Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin. FEMS Immunol. Med. Microbiol. 18:105-112.
20. Prasad, R., P. de Wergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans. CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
21. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
22. Ruhnke, M., A. Schmidt-Westhausen, and M. Trautmann. 1997. In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection. Antimicrob. Agents Chemother. 41:575-577.
23. Valenti, P., P. Visca, G. Antonini, and N. Orsi. 1986. Interaction between lactoferrin and ovotransferrin and Candida cells. FEMS Microbiol. Lett. 33: 271-275.
24. Wakabayashi, H., S. Abe, T. Okutomi, S. Tansho, K. Kawase, and H. Yamaguchi. 1996. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents. Microbiol. Immunol. 40: 821-825.
25. Wakabayashi, H., T. Hiratani, K. Uchida, and H. Yamaguchi. 1996. Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J. Infect. Chemother. 1:185-189.